Damo, Jen-jen M.
HRN: 17-06-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
DOXYCYCLINE 100MG (CAP)
08/23/2022
09/06/2022
ORAL
100 Mg
BID
Severe Pelvic Inflammatory Disease
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes